• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促凋亡蛋白BIM与抗凋亡蛋白BCL-XL在MYC诱导淋巴瘤发生过程中的功能拮抗作用。

Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis.

作者信息

Delbridge A R D, Grabow S, Bouillet P, Adams J M, Strasser A

机构信息

1] Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia [2] Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.

出版信息

Oncogene. 2015 Apr 2;34(14):1872-6. doi: 10.1038/onc.2014.132. Epub 2014 May 26.

DOI:10.1038/onc.2014.132
PMID:24858047
Abstract

Genomic analyses revealed that many cancers have acquired abnormalities in their expression of pro- or anti-apoptotic members of the BCL-2 protein family. It is, however, unknown whether changes in pro- or anti-apoptotic BCL-2 family members have similar impact on tumorigenesis or whether changes in one subgroup have disproportionate impact. We compared the consequences of concomitant loss of anti-apoptotic Bclx and pro-apoptotic Bim on MYC-induced lymphomagenesis. Whereas only loss of both Bclx alleles markedly forestalled tumorigenesis, loss of a single Bim allele overcame this blockade. Conversely, loss of even a single Bim allele sufficed to substantially accelerate lymphomagenesis, and only loss of both but not loss of a single allele of Bclx could attenuate this acceleration. The evidence that modest (two-fold) monoallelic changes in the expression of at least some BH3-only proteins can profoundly impact tumorigenesis suggests that such aberrations, imposed by epigenetic or genetic changes, may expedite tumorigenesis more effectively than elevated expression of pro-survival BCL-2 family members. These findings further our understanding of the mechanisms of lymphomagenesis and possibly also cancer therapy.

摘要

基因组分析显示,许多癌症在其BCL-2蛋白家族促凋亡或抗凋亡成员的表达上出现了异常。然而,促凋亡或抗凋亡的BCL-2家族成员的变化对肿瘤发生是否有相似的影响,或者一个亚组的变化是否有不成比例的影响,目前尚不清楚。我们比较了抗凋亡蛋白Bclx和促凋亡蛋白Bim同时缺失对MYC诱导的淋巴瘤发生的影响。只有两个Bclx等位基因都缺失才会显著延缓肿瘤发生,而单个Bim等位基因的缺失则克服了这种阻滞。相反,即使单个Bim等位基因的缺失也足以显著加速淋巴瘤的发生,只有两个Bclx等位基因都缺失而不是单个等位基因缺失才能减弱这种加速作用。至少一些仅含BH3结构域的蛋白表达发生适度(两倍)单等位基因变化就能深刻影响肿瘤发生,这一证据表明,由表观遗传或基因变化导致的此类畸变可能比促生存BCL-2家族成员的高表达更有效地加速肿瘤发生。这些发现加深了我们对淋巴瘤发生机制的理解,也可能有助于癌症治疗。

相似文献

1
Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis.促凋亡蛋白BIM与抗凋亡蛋白BCL-XL在MYC诱导淋巴瘤发生过程中的功能拮抗作用。
Oncogene. 2015 Apr 2;34(14):1872-6. doi: 10.1038/onc.2014.132. Epub 2014 May 26.
2
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1.c-Myc 依赖性表达促凋亡 Bim 使 HER2 过表达的乳腺癌细胞依赖抗凋亡 Mcl-1。
Mol Cancer. 2011 Sep 7;10:110. doi: 10.1186/1476-4598-10-110.
3
Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression.Bim 必须能够与所有的抗凋亡 Bcl-2 家族成员结合,以有效抑制肿瘤。
Oncogene. 2012 Jul 12;31(28):3392-6. doi: 10.1038/onc.2011.508. Epub 2011 Nov 14.
4
c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.c-Myc过表达通过调节Bcl-2/Bcl-xL的表达,使Bim介导的Bax激活对组蛋白去乙酰化酶抑制剂辛二酰苯胺异羟肟酸(SAHA)诱导的细胞凋亡敏感。
Int J Biochem Cell Biol. 2007;39(5):1016-25. doi: 10.1016/j.biocel.2007.01.024. Epub 2007 Feb 2.
5
The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver.Bcl-2 同源结构域 3(BH3)-仅有蛋白 Bim 和 bid 在健康的肝脏中是有功能活性的,并受到抗凋亡 Bcl-2 家族蛋白的限制。
J Biol Chem. 2013 Oct 18;288(42):30009-30018. doi: 10.1074/jbc.M112.443093. Epub 2013 Aug 28.
6
The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.BH3 ɑ 螺旋模拟物 BH3-M6 可破坏 Bax、Bak、Bad 或 Bim 与 Bcl-X(L)、Bcl-2 和 MCL-1 蛋白-蛋白相互作用,并以 Bax 和 Bim 依赖的方式诱导细胞凋亡。
J Biol Chem. 2011 Mar 18;286(11):9382-92. doi: 10.1074/jbc.M110.203638. Epub 2010 Dec 9.
7
The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism.突变型KRAS基因通过STAT3上调BCL-XL蛋白以赋予抗凋亡能力,而BIM蛋白诱导和BCL-XL拮抗可逆转这种抗凋亡能力。
J Biol Chem. 2015 Sep 25;290(39):23838-49. doi: 10.1074/jbc.M115.657833. Epub 2015 Aug 5.
8
Potential synergism of Bim with p53 in mice with Myc‑induced lymphoma in a mouse lymphoma model.在一个鼠淋巴瘤模型中,Bim 与 p53 在 Myc 诱导的淋巴瘤小鼠中的潜在协同作用。
Mol Med Rep. 2012 Jun;5(6):1401-8. doi: 10.3892/mmr.2012.844. Epub 2012 Mar 22.
9
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.BCL-xL在亚细胞膜上对BH3蛋白的紧密隔离导致细胞凋亡抗性。
Cell Rep. 2016 Dec 20;17(12):3347-3358. doi: 10.1016/j.celrep.2016.11.064.
10
Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.内源性 Bcl-xL 对于 Myc 驱动的小鼠淋巴瘤发生是必需的。
Blood. 2011 Dec 8;118(24):6380-6. doi: 10.1182/blood-2011-07-367672. Epub 2011 Oct 12.

引用本文的文献

1
Novel BRD4-p53 Inhibitor SDU-071 Suppresses Proliferation and Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells.新型BRD4-p53抑制剂SDU-071抑制MDA-MB-231三阴性乳腺癌细胞的增殖和迁移。
ACS Pharmacol Transl Sci. 2024 Mar 12;7(4):1178-1190. doi: 10.1021/acsptsci.4c00057. eCollection 2024 Apr 12.
2
Apoptotic cell death in disease-Current understanding of the NCCD 2023.疾病中的细胞凋亡性死亡——2023 年对 NCCD 的最新理解。
Cell Death Differ. 2023 May;30(5):1097-1154. doi: 10.1038/s41418-023-01153-w. Epub 2023 Apr 26.
3
Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.

本文引用的文献

1
The role of the apoptotic machinery in tumor suppression.凋亡机制在肿瘤抑制中的作用。
Cold Spring Harb Perspect Biol. 2012 Nov 1;4(11):a008789. doi: 10.1101/cshperspect.a008789.
2
Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice.BH3 模拟物 ABT-737 的预防性治疗可阻止 Myc 驱动的小鼠淋巴瘤发生。
Cell Death Differ. 2013 Jan;20(1):57-63. doi: 10.1038/cdd.2012.92. Epub 2012 Jul 20.
3
Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.
抑制 BRD4 通过增强 FOXO1 表达抑制前列腺癌肿瘤生长。
Int J Oncol. 2018 Dec;53(6):2503-2517. doi: 10.3892/ijo.2018.4577. Epub 2018 Sep 27.
4
Measurement of BH3-only protein tolerance.BH3 仅蛋白耐受度的测量。
Cell Death Differ. 2018 Feb;25(2):282-293. doi: 10.1038/cdd.2017.156. Epub 2017 Oct 20.
5
Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.潜伏膜蛋白1(LMP1)和LMP2A协同作用促进爱泼斯坦-巴尔病毒诱导的脐带血人源化小鼠模型中的B细胞淋巴瘤,但这并非必需。
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.01928-16. Print 2017 Apr 1.
6
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis.泛癌分析将PARK2与依赖BCL-XL的细胞凋亡调控联系起来。
Neoplasia. 2017 Feb;19(2):75-83. doi: 10.1016/j.neo.2016.12.006. Epub 2016 Dec 27.
7
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.在多种急性淋巴细胞白血病转基因小鼠模型中,BIM介导癌基因失活诱导的细胞凋亡。
Oncotarget. 2016 May 10;7(19):26926-34. doi: 10.18632/oncotarget.8731.
8
Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis.内源性MCL-1在c-MYC诱导的淋巴瘤发生中的关键B淋巴细胞内在作用。
Cell Death Dis. 2016 Mar 10;7(3):e2132. doi: 10.1038/cddis.2016.43.
9
The BCL-2 protein family, BH3-mimetics and cancer therapy.BCL-2蛋白家族、BH3模拟物与癌症治疗
Cell Death Differ. 2015 Jul;22(7):1071-80. doi: 10.1038/cdd.2015.50. Epub 2015 May 8.
Bcl-2、Bcl-x(L) 和 Bcl-w 并非 ABT-737 和 navitoclax(ABT-263)在淋巴样和白血病细胞中的等效靶点。
Blood. 2012 Jun 14;119(24):5807-16. doi: 10.1182/blood-2011-12-400929. Epub 2012 Apr 26.
4
Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.内源性 Bcl-xL 对于 Myc 驱动的小鼠淋巴瘤发生是必需的。
Blood. 2011 Dec 8;118(24):6380-6. doi: 10.1182/blood-2011-07-367672. Epub 2011 Oct 12.
5
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.解析细胞程序性死亡的规律以提高癌症和其他疾病的治疗效果。
EMBO J. 2011 Aug 23;30(18):3667-83. doi: 10.1038/emboj.2011.307.
6
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.DNA 损伤诱导治疗杀死淋巴瘤细胞需要 p53 靶点 Puma 和 Noxa,但也需要 Bim。
Blood. 2010 Dec 9;116(24):5256-67. doi: 10.1182/blood-2010-04-280818. Epub 2010 Sep 9.
7
Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death.促进细胞凋亡的肿瘤发生:γ 射线诱导的胸腺淋巴瘤发生需要 Puma 驱动的白细胞死亡。
Genes Dev. 2010 Aug 1;24(15):1608-13. doi: 10.1101/gad.1940110.
8
The landscape of somatic copy-number alteration across human cancers.人类癌症中体细胞拷贝数改变的全景。
Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.
9
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics.通过BH3模拟物释放致癌激酶抑制剂的力量。
Nat Rev Cancer. 2009 May;9(5):321-6. doi: 10.1038/nrc2615. Epub 2009 Apr 3.
10
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.彪马(Puma)以及在较小程度上的诺夏(Noxa)是Myc诱导淋巴瘤发生的抑制因子。
Cell Death Differ. 2009 May;16(5):684-96. doi: 10.1038/cdd.2008.195. Epub 2009 Jan 16.